Chris Malmberg’s abstract entitled “Total synthesis of clavatadine A analogues to produce a viable reversible inhibitor of factor XIa” was accepted by the American Chemical Society Division of Medicinal Chemistry. Chris will present his poster at the Spring 2015 national meeting of the ACS in Denver this March. Congratulations Chris! If you go to the meeting, please visit his poster on Sunday evening, March 22, 2015.
ACS Abstract Accepted